Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Minoxidil effectively treats hair loss, with better results in women.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Menopause affects hair and skin; more research needed for treatment.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lupus can cause hair loss and nail changes, with treatments available for both.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.